welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Celecoxib, DFMO combination improved adenoma burden in patients with familial adenomatous polyposis
In a randomized clinical chemoprevention trial, a combination of celecoxib and diflouromethylornithine resulted in a nonsignificant benefit among patients with familial adenomatous polyposis when adenoma count in a defined area was used as the primary endpoint. However, the combination was well tolerated, and a secondary measure of adenoma burden using a video-based global assessment showed a significant incremental benefit.
expertly curated content related to this topic
-
Lahey Hospital and Medical CenterLahey Hospital & Medical Center is a...
-
Albert de la Chapelle, MD, PhDResearch in Dr. de la Chapelle’s labor...
-
Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis in ChildrenPURPOSE : This study was designed to eva...
-
Significantly Increased Pregnancy Rates After Laparoscopic Restorative Proctocolectomy: A Cross-sectional StudyOBJECTIVE: To assess the impact of a la...
-
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP)A study to evaluate rofecoxib in the tre...
-
Total Proctocolectomy, Ileal Pouch Anal Anastomosis (J-Pouch, S-Pouch, W-Pouch)http://my.clevelandclinic.org/ccf/media/...
-
Considerations and Complications in Patients Undergoing Ileal Pouch Anal AnastomosisTotal proctocolectomy with ileal pouch a...